Facing unprecedented changes from government health care reform, device approval regulations, changes to sales relationships, and shifts in buying power, medical device manufacturers are under extraordinary profit pressure. This paper explores the implications of these challenges and the four essential strategies required to gain control over pricing processes, define product value, and increase profit visibility.
Kalypso is the world’s premier innovation consulting firm, helping clients improve performance by delivering on the promise of innovation. Kalypso offers clients full service capabilities including Business and Innovation Strategy, Front End of Innovation, Portfolio and Pipeline Management, New Product Development and Introduction, Pricing and Value Management, PLM Technology, Leadership and Learning, and Intellectual Property Management. For more information, visit http://kalypso.com. Follow @KalypsoLP on Twitter and on Facebook at http://facebook.com/KalypsoLP.